Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Marc de Garidel, an experienced leader in the biopharma sector, was appointed CEO in 2023 to lead Abivax as it moves towards commercialization of its lead drug candidate, obefazimod, currently tested in phase 3 trials for the treatment of adults with moderately to severely active ulcerative colitis (UC). I recently talked with him about leadership and lessons he has learned over his career.

The Alliance for Regenerative Medicine (ARM) is an international advocacy organization championing the benefits of engineered cell therapies and genetic medicines. Tim Hunt joined ARM as CEO in 2022 with more than 20 years of experience in the biotechnology industry.

Recruiting for diversity is not about checking a box. We see it as a strategic, forward-looking solution that positively affects culture, competitiveness, and innovation. With today’s highly competitive talent pool, recruiters need to expand their reach and look beyond the

For anyone working in executive recruiting, it is clear that there is no one-size-fits-all when it comes to choosing a CEO for an organization. Whether a company is just starting out, needs a cultural turnaround, or is making moves to

NEW YORK, December 8, 2021 – Catalyst Advisors LP, an international executive recruitment and assessment firm singularly focused on life sciences, announced the appointment of a new hire: Melanie Magsaysay has joined as a Project Manager based in New York.

OPINION Today, the demand for new board members is immense. Start-up companies, including those in the biopharma industry, are aggressively pursuing listings, which requires them to add independent and diverse members. Once a company is public, investors need to cycle